Lamivudine

We are offering lamivudine.
Lamivudine is a reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat hiv disease. Lamivudine is a hepatitis b virus nucleoside analog reverse transcriptase inhibitor and human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor. The mechanism of action of lamivudine is as a nucleoside reverse transcriptase inhibitor. The chemical classification of lamivudine is nucleoside analog.
Lamivudine is a synthetic nucleoside analogue with activity against hepatitis b virus (hbv) and hiv. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvinetriphosphate (l-tp) and lamiduvine monophosphate (l-mp). In hiv, l-tp inhibits hiv-1 reverse transcriptase (rt) via dna chain termination after incorporation of the nucleoside analogue into viral dna. In hbv, incorporation of l-mp into viral dna by hbv polymerase results in dna chain termination; l-tp is a weak inhibitor of mammalian dna polymerases alpha and beta, and mitochondrial dna polymerase.
synonyms: 4-amino-1-[(2r, 5s)-2-(hydroxymethyl)-1, 3-oxathiolan-5-yl] pyrimidin-2-one
cas number: 134678-17-4, mol. Formula: c8h11n3o3s, mol.weight: 229.26
lamivudine is white crystalline powder. It is soluble in water (46 mgml at 25 °c), dmso (46 mgml at 25 °c), methanol, and ethanol (